Concerning Immunosuppression

Editorial Article

Dr. Thomas Ryzlewicz
Organ Transplantation had developed to a regular therapy since more than 35 years. Tremendous success had reached. Looking the results over the decades, a clear improvement of the survival of the organs had reached in the first years following the individual transplantation. An essential part of this great success have the Immunosuppressive Drugs. They became strong and stronger. Comparable to other drugs, these immunosuppressive drugs also have undesired secondary effects. That is quite regular.

Published: 04 Dec 2015


Augmented Alveolar Corticotomy and Accelerated Orthodontics: In-vivo Tissue Engineering

Conference Proceeding

Dr. Donald J. Ferguson

Outpatient surgical injury of cortical alveolar bone combined with augmentation bone grafting is called Periodontally Accelerated Osteogenic Orthodontics (PAOO) and is most recognized for reducing active orthodontic treatment times 3X to 4X times (6 months instead of 2 to 3 years).

Published: 27 Apr 2017


The Regentime Procedure for Organ Regeneration, Transplantation of Mobilized Autologous Adult Bone Marrow Derived Human Progenitor Cells Incubated with Organ-Specific- Xeno-Ultra- Filtrates

Conference Proceeding

Dr. Nassim Abi Chahine

Over a period of seven years, three hundreds patients with different chronic disorders were monitored after the treatment with autologous bone marrow derived stem cells. Our field of study covered a wide range of diseases and multiple protocols were developed and explored

Published: 27 Apr 2017

View All

Scope of the Journal

International Journal of Transplantation Research and Technology

The journal aims to provide rapid publication of new high quality data in organ and tissue transplantation and the related sciences. The journal is directed at scientists and clinicians in transplantation and also those in other fields who wish to follow transplantation.

The journal strives to make cutting edge research available to the young scientists and the entire scientific community so that they can utilize them to contribute to the innovation that drives the medical science. The journal provides an extensive and collaborative research by pooling the information derived from the researches.

Editorial Board

Editor In Chief

Dr. William Tse

Chief, University of Louisville Hospital, USA

CO Editor In Chief

Dr. Gerhard C. Hildebrandt

Division Chief, University of Kentucky, USA

Editorial Board

Dr. Thomas Ryzlewicz

ViaMedis Dialysis Center, Germany

Dr. Wei An

University of Nebraska Medical Center, USA

View All

Research Topics

☛ Anti-HLA antibodies
☛ Clinical Immunosuppression
☛ Crossmatch strategies
☛ Immunotherapy
☛ Internal medicine
☛ Liver Transplantation
☛ Mesenchymal stem cells
☛ Preservation and transplantation
☛ Public Health
☛ Targeted therapeutics and biomarkers
☛ Toxicogenomic processes
☛ Tumor microenvironment

Editorial office